Scholars Central

Short communicationPublished 10 May 2017

Why is pharma so scared of psychiatric drug discovery?

Authors: Mark D Tricklebank, Laura A Ajram

Integrative Neuroscience Research

Volume 1 · Issue 1 · Pages 1–4

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The 1950s heralded a golden age for psychiatric drug discovery; for the first time, compounds capable of treating serious mental disturbances were found that, despite their shortcomings, proved the pharmacotherapy of mental disorders was both possible and effective. Not only did these early treatments unlock the Victorian asylums and allow a more humane attitude to mental illness, they also led to the founding of modern neuroscience approaches to understanding the function and dysfunction of the most complex object in the universe- the human brain.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Integrative Neuroscience Research.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalIntegrative Neuroscience Research
  • SubjectNeuroscience & Neurology
  • BylineArticles whose byline prints “Mark D Tricklebank”
  • BylineArticles whose byline prints “Laura A Ajram”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels